U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Showing 1 - 10 of 10 results

SECUKINUMAB

MORE DETAILS

DLG4EML025

Protein
Status:
US Approved Rx (2023)
First approved in 2015
Class:
PROTEIN

MEPOLIZUMAB

MORE DETAILS

90Z2UF0E52

Protein
Status:
US Approved Rx (2015)
First approved in 2015
Class:
PROTEIN

TOCILIZUMAB

MORE DETAILS

I031V2H011

Protein
Status:
US Approved Rx (2013)
First approved in 2010
Class:
PROTEIN

CANAKINUMAB

MORE DETAILS

37CQ2C7X93

Protein
Status:
US Approved Rx (2009)
First approved in 2009
Class:
PROTEIN

USTEKINUMAB

MORE DETAILS

FU77B4U5Z0

Protein
Status:
US Approved Rx (2024)
First approved in 2009
Class:
PROTEIN

RILONACEPT

MORE DETAILS

8K80YB5GMG

Protein
Status:
US Approved Rx (2008)
First approved in 2008
Class:
PROTEIN

ANAKINRA

MORE DETAILS

9013DUQ28K

Protein
Status:
US Approved Rx (2001)
First approved in 2001
Class:
PROTEIN

BASILIXIMAB

MORE DETAILS

9927MT646M

Protein
Status:
US Approved Rx (1998)
First approved in 1998
Class:
PROTEIN

DACLIZUMAB

MORE DETAILS

CUJ2MVI71Y

Protein
Status:
US Approved Rx (2016)
First approved in 1997
Class:
PROTEIN

BRIAKINUMAB

MORE DETAILS

978I8M0P8X

Protein
Status:
Possibly Marketed Outside US
Class:
PROTEIN
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966